Simple Peptide Quantification Approach for MS-Based Proteomics Quality Control.


Journal

ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658

Informations de publication

Date de publication:
31 Mar 2020
Historique:
received: 07 01 2020
accepted: 04 03 2020
entrez: 8 4 2020
pubmed: 8 4 2020
medline: 8 4 2020
Statut: epublish

Résumé

Despite its growing popularity and use, bottom-up proteomics remains a complex analytical methodology. Its general workflow consists of three main steps: sample preparation, liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS), and computational data analysis. Quality assessment of the different steps and components of this workflow is instrumental to identify technical flaws and avoid loss of precious measurement time and sample material. However, assessment of the extent of sample losses along with the sample preparation protocol, in particular, after proteolytic digestion, is not yet routinely implemented because of the lack of an accurate and straightforward method to quantify peptides. Here, we report on the use of a microfluidic UV/visible spectrophotometer to quantify MS-ready peptides directly in the MS-loading solvent, consuming only 2 μL of sample. We compared the performance of the microfluidic spectrophotometer with a standard device and determined the optimal sample amount for LC-MS/MS analysis on a Q Exactive HF mass spectrometer using a dilution series of a commercial K562 cell digest. A careful evaluation of selected LC and MS parameters allowed us to define 3 μg as an optimal peptide amount to be injected into this particular LC-MS/MS system. Finally, using tryptic digests from human HEK293T cells and showing that injecting equal peptide amounts, rather than approximate ones, result in less variable LC-MS/MS and protein quantification data. The obtained quality improvement together with easy implementation of the approach makes it possible to routinely quantify MS-ready peptides as a next step in daily proteomics quality control.

Identifiants

pubmed: 32258910
doi: 10.1021/acsomega.0c00080
pmc: PMC7114614
doi:

Types de publication

Journal Article

Langues

eng

Pagination

6754-6762

Informations de copyright

Copyright © 2020 American Chemical Society.

Déclaration de conflit d'intérêts

The authors declare no competing financial interest.

Références

J Proteome Res. 2018 Jan 5;17(1):727-738
pubmed: 29183128
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Anal Chem. 2017 Apr 18;89(8):4474-4479
pubmed: 28318237
Nat Commun. 2018 Feb 28;9(1):882
pubmed: 29491378
Nat Methods. 2016 Nov 29;13(12):964-966
pubmed: 27898063
J Chromatogr A. 2010 Feb 5;1217(6):858-80
pubmed: 20031138
Proteomics. 2017 Feb;17(3-4):
pubmed: 27549080
Anal Bioanal Chem. 2003 Aug;376(7):946-51
pubmed: 12856097
Anal Chem. 2015 Apr 21;87(8):4110-6
pubmed: 25837572
Mass Spectrom Rev. 2018 Sep;37(5):697-711
pubmed: 28802010
Methods Mol Biol. 2012;917:391-407
pubmed: 22956100
J Proteome Res. 2018 Jan 5;17(1):420-428
pubmed: 29083196
Cell Syst. 2017 Jun 28;4(6):587-599.e4
pubmed: 28601559
Acta Pharm Sin B. 2016 Nov;6(6):540-551
pubmed: 27818920
Proteomics. 2017 May;17(9):
pubmed: 28266123
J Proteome Res. 2018 Apr 6;17(4):1730-1740
pubmed: 29565595
Mol Cell Proteomics. 2017 Apr;16(4):694-705
pubmed: 28126900
Mol Cell Proteomics. 2018 Nov;17(11):2284-2296
pubmed: 30104208
J Chromatogr A. 2006 Jul 7;1120(1-2):165-72
pubmed: 16472536
Nat Methods. 2014 Mar;11(3):319-24
pubmed: 24487582
Mol Cell Proteomics. 2018 Dec;17(12):2534-2545
pubmed: 30385480
Mol Cell Proteomics. 2010 Feb;9(2):225-41
pubmed: 19837981
Mol Cell Proteomics. 2019 May;18(5):1027-1035
pubmed: 30833379
Mol Cell Proteomics. 2014 Sep;13(9):2513-26
pubmed: 24942700
Biology (Basel). 2014 Mar 11;3(1):205-19
pubmed: 24833342
PLoS One. 2018 Jan 11;13(1):e0189209
pubmed: 29324744
Anal Chem. 2003 Jul 15;75(14):3404-10
pubmed: 14570190
Clin Biochem. 2013 Apr;46(6):411-20
pubmed: 23246537
J Biomol Tech. 2013 Dec;24(4):187-97
pubmed: 24294112
Front Microbiol. 2019 Feb 14;10:238
pubmed: 30837968

Auteurs

Teresa Mendes Maia (TM)

VIB Center for Medical Biotechnology, Albert Baertsoenkaai 3, Ghent 9000, Belgium.
Department of Biomolecular Medicine, Ghent University, Albert Baertsoenkaai 3, Ghent 9000, Belgium.
VIB Proteomics Core, Albert Baertsoenkaai 3, Ghent 9000, Belgium.

An Staes (A)

VIB Center for Medical Biotechnology, Albert Baertsoenkaai 3, Ghent 9000, Belgium.
Department of Biomolecular Medicine, Ghent University, Albert Baertsoenkaai 3, Ghent 9000, Belgium.
VIB Proteomics Core, Albert Baertsoenkaai 3, Ghent 9000, Belgium.

Kim Plasman (K)

Alzheimer Research Foundation, Kalkhoevestraat 1, Waregem 8790, Belgium.

Jarne Pauwels (J)

VIB Center for Medical Biotechnology, Albert Baertsoenkaai 3, Ghent 9000, Belgium.
Department of Biomolecular Medicine, Ghent University, Albert Baertsoenkaai 3, Ghent 9000, Belgium.
VIB Proteomics Core, Albert Baertsoenkaai 3, Ghent 9000, Belgium.

Katie Boucher (K)

VIB Center for Medical Biotechnology, Albert Baertsoenkaai 3, Ghent 9000, Belgium.
Department of Biomolecular Medicine, Ghent University, Albert Baertsoenkaai 3, Ghent 9000, Belgium.
VIB Proteomics Core, Albert Baertsoenkaai 3, Ghent 9000, Belgium.

Andrea Argentini (A)

VIB Center for Medical Biotechnology, Albert Baertsoenkaai 3, Ghent 9000, Belgium.
Department of Biomolecular Medicine, Ghent University, Albert Baertsoenkaai 3, Ghent 9000, Belgium.
Bioinformatics Institute Ghent, Ghent University, Ghent 9000, Belgium.

Lennart Martens (L)

VIB Center for Medical Biotechnology, Albert Baertsoenkaai 3, Ghent 9000, Belgium.
Department of Biomolecular Medicine, Ghent University, Albert Baertsoenkaai 3, Ghent 9000, Belgium.
Bioinformatics Institute Ghent, Ghent University, Ghent 9000, Belgium.

Tony Montoye (T)

Business Development Management, VIB, Ghent 9000, Belgium.

Kris Gevaert (K)

VIB Center for Medical Biotechnology, Albert Baertsoenkaai 3, Ghent 9000, Belgium.
Department of Biomolecular Medicine, Ghent University, Albert Baertsoenkaai 3, Ghent 9000, Belgium.

Francis Impens (F)

VIB Center for Medical Biotechnology, Albert Baertsoenkaai 3, Ghent 9000, Belgium.
Department of Biomolecular Medicine, Ghent University, Albert Baertsoenkaai 3, Ghent 9000, Belgium.
VIB Proteomics Core, Albert Baertsoenkaai 3, Ghent 9000, Belgium.

Classifications MeSH